Publications by authors named "Jan van Laar"

Claim this Profile
N
NTRK1-rearranged histiocytosis: clinicopathologic and molecular features.
Rivers Fragneau, Sylvie Fraitag, Paul G Kemps, Zofia Hélias-Rodzewicz, Somak Roy, Jan A M van Laar

Blood Adv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Driver mutations in myeloid and lymphoid cells point to multipotent progenitor origin of diverse histiocytic neoplasms.
Astrid G S van Halteren, Paul G Kemps, Jelske Forma-Borst, Yanling Xiao, Maud A J I van den Oetelaar, Jan A M van Laar

Blood Neoplasia· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent ETV3::NCOA2 fusions and MAPK pathway mutations in indeterminate dendritic cell histiocytosis.
Paul G Kemps, F J Sherida H Woei-A-Jin, Koen D Quint, Cor van den Bos, Leonie Naeije, Jan A M van Laar

Blood Adv· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicentre, 26-week, open-label phase 2 trial of the JAK inhibitor filgotinib in Behçet's disease, idiopathic inflammatory myopathies and IgG4-related disease: DRIMID study protocol.
Bettina C Geertsema-Hoeve, Jan A M van Laar, Joost Raaphorst, Sander W Tas, Paco M J Welsing, Jacob M van Laar

BMJ Open· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationship between immunoglobulin G4-related disease and malignancy.
Faiz Karim, Jan van Laar

Reumatologia· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of red flags for IgG4-related disease: an international European Reference Network for Rare Connective Tissue Diseases framework.
Emanuel Della-Torre, Rosaria Talarico, Jose Ballarin, Emanuele Bozzalla-Cassione, Chiara Cardamone, Jan A M van Laar

Lancet Rheumatol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unexpected finding of encapsulating peritoneal sclerosis: mind the cocoon.
Eva van Boven, Robert R J Coebergh van den Braak, Jan van Laar, Michiel G H Betjes

BMJ Case Rep· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent CLTC::SYK fusions and CSF1R mutations in juvenile xanthogranuloma of soft tissue.
Paul G Kemps, Hans J Baelde, Ruben H P Vorderman, Ellen Stelloo, Joost F Swennenhuis, Jan A M van Laar

Blood· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy or Immunotherapy in Behçet's Disease?
Jan A M van Laar, Tim B van der Houwen

NEJM Evid· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Follow-Up of Patients with Scleritis After Rituximab Treatment Including B Cell Monitoring.
Kiki van Bilsen, Daphne P C Vergouwen, Mirjam E J van Velthoven, Tom O A R Missotten, Saskia M Rombach, Jan A M van Laar

Ocul Immunol Inflamm· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A serum B-lymphocyte activation signature is a key distinguishing feature of the immune response in sarcoidosis compared to tuberculosis.
Ikhwanuliman Putera, Benjamin Schrijver, P Martijn Kolijn, Astrid C van Stigt, Josianne C E M Ten Berge, Jan A M van Laar

Commun Biol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased serum interferon activity in sarcoidosis compared to that in tuberculosis: Implication for diagnosis?
Benjamin Schrijver, Jens Göpfert, Rina La Distia Nora, Ikhwanuliman Putera, Nicole M A N Nagtzaam, Jan A M van Laar

Heliyon· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world experience with targeted therapy in patients with histiocytic neoplasms in the Netherlands and in Belgium.
Paul G Kemps, F J Sherida H Woei-A-Jin, Patrick Schöffski, Thomas Tousseyn, Isabelle Vanden Bempt, Jan A M van Laar

Blood Neoplasia· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A dens fracture case solved.
Ling Oei, Jiawei Li, A Faiz Karim, Robert M Verdijk, Edwin H G Oei, Jan A M van Laar

Rheumatology (Oxford)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Somatostatin analogues as a treatment option for cystoid maculopathy in retinitis pigmentosa.
Pam A T Heutinck, L Ingeborgh van den Born, Jan A M van Laar, P Martin van Hagen, Dzenita Smailhodzic

BMJ Open Ophthalmol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Timing and Mechanisms of Nanodiamond Uptake in Colon Cancer Cells.
Alina Sigaeva, Runrun Li, Jan Jelle van Laar, Leon Wierenga, Romana Schirhagl

Nanotechnol Sci Appl· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expanding treatment options by selectively targeting the cytokine storm with ruxolitinib in primary hemophagocytic lymphohistiocytosis.
Jan A M Van Laar

Haematologica· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extensive, circumferential, epidural spinal cord compression by IgG4-related pachymeningitis.
Finn Segers, Jan Am van Laar, Johanna Am Wijbenga, Godard Cw de Ruiter

BMJ Case Rep· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRAF V600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosis.
Aldo A Acosta-Medina, Paul G Kemps, Timo C E Zondag, Jithma P Abeykoon, Jelske Forma-Borst, Jan A M van Laar

Blood· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digital Outcome Measurement to Improve Care for Patients With Immune-Mediated Inflammatory Diseases: Protocol for the IMID Registry.
Agnes E M Looijen, Reinier C A van Linschoten, Jan-Dietert Brugma, Dirk Jan Hijnen, Pascal H P de Jong, Jan A M van Laar

JMIR Res Protoc· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicogenomic associations in childhood Langerhans cell histiocytosis: an international cohort study.
Paul G Kemps, Timo C E Zondag, Helga B Arnardóttir, Nienke Solleveld-Westerink, Jelske Borst, Jan A M van Laar

Blood Adv· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treat to target in Behcet's disease: Should we follow the paradigm of other systemic rheumatic diseases?
George E Fragoulis, George Bertsias, Bahram Bodaghi, Ahmet Gul, Jan van Laar

Clin Immunol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of etoposide in the treatment of adult patients with hemophagocytic lymphohistiocytosis.
Timo C E Zondag, Aglina Lika, Jan A M van Laar

Exp Hematol Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the First SARS-CoV-2 Lockdown on Adherence to Biological Treatment in Patients with Immune-Mediated Inflammatory Diseases in the Netherlands.
Romy van der Groef, Pascal H P de Jong, Dirk Jan Hijnen, Christien J van der Woude, Jan A M van Laar

Patient Prefer Adherence· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aggressive unifocal bone Langerhans cell histiocytosis with soft tissue extension both responsive to radiotherapy: a case report.
Wilmar Ghuijs, Paul G Kemps, Marta E Capala, Robert M Verdijk, Astrid G S van Halteren, Jan A M van Laar

Radiat Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis